Shandong Sinobioway Biomedicine Co., Ltd.
002581.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2,438,106 | CN¥9,632,647 | CN¥10,390,835 | CN¥14,085,355 |
| - Cash | CN¥506,404 | CN¥151,912 | CN¥183,803 | CN¥187,797 |
| + Debt | CN¥2,766 | CN¥14,547 | CN¥165,349 | CN¥177,161 |
| Enterprise Value | CN¥1,934,469 | CN¥9,495,283 | CN¥10,372,382 | CN¥14,074,719 |
| Revenue | CN¥360,405 | CN¥429,790 | CN¥357,081 | CN¥402,713 |
| % Growth | -16.1% | 20.4% | -11.3% | – |
| Gross Profit | CN¥287,548 | CN¥336,503 | CN¥280,869 | CN¥316,879 |
| % Margin | 79.8% | 78.3% | 78.7% | 78.7% |
| EBITDA | -CN¥104,309 | -CN¥233,982 | -CN¥110,626 | -CN¥144,379 |
| % Margin | -28.9% | -54.4% | -31% | -35.9% |
| Net Income | -CN¥137,314 | -CN¥332,458 | -CN¥14,680 | CN¥271,002 |
| % Margin | -38.1% | -77.4% | -4.1% | 67.3% |
| EPS Diluted | -0.6 | -0.5 | -0.022 | 0.41 |
| % Growth | -20% | -2,142.2% | -105.4% | – |
| Operating Cash Flow | -CN¥6,547 | -CN¥36,506 | -CN¥54,485 | -CN¥46,015 |
| Capital Expenditures | -CN¥9,014 | -CN¥4,319 | -CN¥31,464 | -CN¥60,846 |
| Free Cash Flow | -CN¥15,561 | -CN¥40,825 | -CN¥85,949 | -CN¥106,861 |